Skip to main content

The Jackson Laboratory

  • Home
    • Autoimmune/Inflammation
    • Essentials
    • Immunology
    • Immuno-oncology/Oncology
    • Infectious Disease
    • Metabolic
    • Neurobiology
    • Rare Disease
    • Blog
    • Case Studies
    • Clinical Education Online Courses
    • eBooks
    • Fact Sheets
    • Guides
    • Livestream Videos
    • JAX Tech Talks
    • On-Demand Videos
    • Online MiniCourses
    • Portfolios
    • White Papers

Recent Searches

    Share this Post

    • Share on facebook
    • Share on twitter
    • Share on linkedin
    • Share on email
    1. Home
    2. Clinical Education Online Courses
    3. Hereditary cancer syndromes: Are your patients at risk? (CME/CNE)

    Hereditary cancer syndromes: Are your patients at risk? (CME/CNE)

    Self-paced • 2.0 credits

    About this course

    This program was developed to help oncology providers identify, evaluate, and manage patients at increased risk of hereditary cancer syndromes. The program was developed by the Michigan State Department of Health and Human Services and The Jackson Laboratory Clinical and Continuing Education Program with funding from the Centers for Disease Control and Prevention.

    Genetic testing is becoming increasingly accessible for patients as the list of clinical indications and number of genes are growing, and the cost of testing is decreasing. Identifying a patient with an underlying genetic variant associated with cancer can impact his or her treatment options, long-term management approach, and risks for other cancer. In addition, there are implications for close family members. While genetic testing can provide important clinical information for decision-making, there are benefits, limitations, and risks. This program focuses on developing skills and knowledge to identify those patients most appropriate for genetic testing, choosing the right test, and using the results to develop a management plan.

     

    ACCESS CME   ACCESS CNE

     

    Learning Objectives

    Upon completion of this educational activity, the learner will be able to:

    • Determine if a patient is a candidate for cancer genetic testing
    • Deliver pre-testing counseling appropriate to the patient
    • Select the best genetic test for the patient
    • Interpret genetic testing results
    • Identify patient management based on genetic testing results

     

    Target Audience

    This activity is designed to meet the educational needs of practicing clinicians who work with cancer patients.

     

    Disclaimer

    All information in Hereditary Cancer Syndromes: Are Your Patients at Risk? is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Hereditary Cancer Syndromes: Are Your Patients at Risk?. Reliance on any information in this program is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Hereditary Cancer Syndromes: Are Your Patients at Risk?

     

    Sign up for this course today!

    ACCESS CME   ACCESS CNE
     
    • Previous Article

      Indications for Germline Testing after Genomic Tumor Testing (CME/CNE)

      Indications for Germline Testing after Genomic Tumor Testing (CME/CNE)

      Interpret genomic tumor test results to determine when a patient should be further evaluated for hereditary (germline) risk.

    • Next Article

      Collecting Family History with Sufficient Detail (CME)

      Collecting Family History with Sufficient Detail (CME)

    Other content in this Stream

    • Choosing the Best Genomic Tumor Test (CME/CNE)

      Choosing the Best Genomic Tumor Test (CME/CNE)

      Learn about the benefits and limitations of different genomic tumor test options for patients with cancer and how to determine the best test for each patient.

      Learn More

    • Indications for Germline Testing after Genomic Tumor Testing (CME/CNE)

      Indications for Germline Testing after Genomic Tumor Testing (CME/CNE)

      Interpret genomic tumor test results to determine when a patient should be further evaluated for hereditary (germline) risk.

      Learn More

    • Collecting Family History with Sufficient Detail (CME)

      Collecting Family History with Sufficient Detail (CME)

      Learn More

    • Collecting Family History with Sufficient Detail (CNE)

      Collecting Family History with Sufficient Detail (CNE)

      Learn More

    • Identifying Red Flags and Patterns that Increase Cancer Risk (CME)

      Identifying Red Flags and Patterns that Increase Cancer Risk (CME)

      Learn More

    • Identifying Red Flags and Patterns that Increase Cancer Risk (CNE)

      Identifying Red Flags and Patterns that Increase Cancer Risk (CNE)

      Learn More

    • Categorizing Cancer Risk (CME)

      Categorizing Cancer Risk (CME)

      Learn More

    • Categorizing Cancer Risk (CNE)

      Categorizing Cancer Risk (CNE)

      Learn More

    • Using Family History to Inform Management (CME)

      Using Family History to Inform Management (CME)

      Learn More

    • Using Family History to Inform Management (CNE)

      Using Family History to Inform Management (CNE)

      Learn More

    • Cancer Genetic Testing Process (CME)

      Cancer Genetic Testing Process (CME)

      Learn More

    • Cancer Genetic Testing Process (CNE)

      Cancer Genetic Testing Process (CNE)

      Learn More

    • Cancer Pretest Decisions & Counseling (CME)

      Cancer Pretest Decisions & Counseling (CME)

      Learn More

    • Cancer Pretest Decisions & Counseling (CNE)

      Cancer Pretest Decisions & Counseling (CNE)

      Learn More

    • Interpreting Cancer Genetic Testing Results (CME)

      Interpreting Cancer Genetic Testing Results (CME)

      Learn More

    • Interpreting Cancer Genetic Testing Results (CNE)

      Interpreting Cancer Genetic Testing Results (CNE)

      Learn More

    • Genetic Testing for Breast Cancer Risk (CME)

      Genetic Testing for Breast Cancer Risk (CME)

      Learn More

    • Genetic Testing for Breast Cancer Risk (CNE)

      Genetic Testing for Breast Cancer Risk (CNE)

      Learn More

    • Genetic Testing for Colorectal Cancer Risk (CME)

      Genetic Testing for Colorectal Cancer Risk (CME)

      Learn More

    • Genetic Testing for Colorectal Cancer Risk (CNE)

      Genetic Testing for Colorectal Cancer Risk (CNE)

      Learn More

    Return to Home
    © The Jackson Laboratory